Viewing Study NCT00258206


Ignite Creation Date: 2025-12-26 @ 1:17 PM
Ignite Modification Date: 2026-01-13 @ 3:41 PM
Study NCT ID: NCT00258206
Status: COMPLETED
Last Update Posted: 2017-12-06
First Post: 2005-11-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Rituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple Myeloma
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization: